Primary Mediastinal B-Cell Lymphoma medications
In this page you will find the list of drugs approved by the FDA to treat Primary Mediastinal B-Cell Lymphoma.
asparaginase (Elspar)
Enzyme-Based Chemotherapy
Learn More arrow_right_alt
blinatumomab (Blincyto)
Bispecific Antibodies
Learn More arrow_right_alt
Calaspargase pegol (Asparlas)
Enzyme-Based Chemotherapy
Learn More arrow_right_alt
cytarabine (Cytosar-U)
Chemotherapy Agents
Learn More arrow_right_alt
dasatinib (Sprycel)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
daunorubicin (Cerubidine)
Chemotherapy Agents
Learn More arrow_right_alt
dexamethasone (Decadron)
Systemic Steroids
Learn More arrow_right_alt
doxorubicin (Adriamycin, Doxil)
Chemotherapy Agents
Learn More arrow_right_alt
ifosfamide (Ifex)
Chemotherapy Agents
Learn More arrow_right_alt
imatinib (Gleevec, Imkeldi)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
inotuzumab ozogamicin (Besponsa)
Antibody-Drug Conjugates
Learn More arrow_right_alt
mercaptopurine (Purinethol, Purixan)
Chemotherapy Agents
Learn More arrow_right_alt
methotrexate (Jylamvo, Trexall, Various, Xatmep)
Chemotherapy Agents
Learn More arrow_right_alt
nilotinib (Tasigna)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
pegaspargase (Oncaspar)
Enzyme-Based Chemotherapy
Learn More arrow_right_alt
tioguanine (Tabloid)
Chemotherapy Agents
Learn More arrow_right_alt
Together we care.
Together we cure.
100% of every dollar you give supports our life-changing mission.